SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-011392
Filing Date
2021-06-01
Accepted
2021-06-01 07:09:07
Documents
44
Period of Report
2021-06-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fhtx-8xkforjefferiesconffd.htm 8-K 29371
2 EX-99.1 finaljune2021foghorninve.htm EX-99.1 34292
3 GRAPHIC finaljune2021foghorninve001.jpg GRAPHIC 64395
4 GRAPHIC finaljune2021foghorninve002.jpg GRAPHIC 247451
5 GRAPHIC finaljune2021foghorninve003.jpg GRAPHIC 81789
6 GRAPHIC finaljune2021foghorninve004.jpg GRAPHIC 81750
7 GRAPHIC finaljune2021foghorninve005.jpg GRAPHIC 116360
8 GRAPHIC finaljune2021foghorninve006.jpg GRAPHIC 115664
9 GRAPHIC finaljune2021foghorninve007.jpg GRAPHIC 114901
10 GRAPHIC finaljune2021foghorninve008.jpg GRAPHIC 50756
11 GRAPHIC finaljune2021foghorninve009.jpg GRAPHIC 115169
12 GRAPHIC finaljune2021foghorninve010.jpg GRAPHIC 94850
13 GRAPHIC finaljune2021foghorninve011.jpg GRAPHIC 110037
14 GRAPHIC finaljune2021foghorninve012.jpg GRAPHIC 124095
15 GRAPHIC finaljune2021foghorninve013.jpg GRAPHIC 62652
16 GRAPHIC finaljune2021foghorninve014.jpg GRAPHIC 126263
17 GRAPHIC finaljune2021foghorninve015.jpg GRAPHIC 99596
18 GRAPHIC finaljune2021foghorninve016.jpg GRAPHIC 110208
19 GRAPHIC finaljune2021foghorninve017.jpg GRAPHIC 141081
20 GRAPHIC finaljune2021foghorninve018.jpg GRAPHIC 95160
21 GRAPHIC finaljune2021foghorninve019.jpg GRAPHIC 66107
22 GRAPHIC finaljune2021foghorninve020.jpg GRAPHIC 124139
23 GRAPHIC finaljune2021foghorninve021.jpg GRAPHIC 120864
24 GRAPHIC finaljune2021foghorninve022.jpg GRAPHIC 112887
25 GRAPHIC finaljune2021foghorninve023.jpg GRAPHIC 60315
26 GRAPHIC finaljune2021foghorninve024.jpg GRAPHIC 114230
27 GRAPHIC finaljune2021foghorninve025.jpg GRAPHIC 110759
28 GRAPHIC finaljune2021foghorninve026.jpg GRAPHIC 111622
29 GRAPHIC finaljune2021foghorninve027.jpg GRAPHIC 92649
30 GRAPHIC finaljune2021foghorninve028.jpg GRAPHIC 58287
31 GRAPHIC finaljune2021foghorninve029.jpg GRAPHIC 107534
32 GRAPHIC finaljune2021foghorninve030.jpg GRAPHIC 119990
33 GRAPHIC finaljune2021foghorninve031.jpg GRAPHIC 112253
34 GRAPHIC finaljune2021foghorninve032.jpg GRAPHIC 55608
35 GRAPHIC finaljune2021foghorninve033.jpg GRAPHIC 108961
36 GRAPHIC finaljune2021foghorninve034.jpg GRAPHIC 98361
37 GRAPHIC finaljune2021foghorninve035.jpg GRAPHIC 59206
38 GRAPHIC finaljune2021foghorninve036.jpg GRAPHIC 107641
39 GRAPHIC finaljune2021foghorninve037.jpg GRAPHIC 103967
40 GRAPHIC finaljune2021foghorninve038.jpg GRAPHIC 93528
41 GRAPHIC finaljune2021foghorninve039.jpg GRAPHIC 103126
42 GRAPHIC finaljune2021foghorninve040.jpg GRAPHIC 41220
43 GRAPHIC finaljune2021foghorninve041.jpg GRAPHIC 109288
44 GRAPHIC finaljune2021foghorninve042.jpg GRAPHIC 107182
  Complete submission text file 0001628280-21-011392.txt   5926679
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39634 | Film No.: 21982932
SIC: 2834 Pharmaceutical Preparations